
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+22
Axion BioSystems suite of live-cell analysis tools offers next-generation solutions for continuous, noninvasive monitoring of in vitro cell models on your benchtop or inside your incubator. From investigating disease mechanisms in neurology and cardiology to developing lifesaving immunotherapies and antivirals, Axions award-winning products are designed to accelerate scientific breakthroughs and transform therapeutic development from discovery to manufacturing. Since launching the revolutionary Maestro multielectrode array (MEA) system in 2008, Axion has continuously expanded its offerings, introducing the premier live-cell analyzer Maestro Z in 2019 and the automated live-cell Omni imager in 2023. Featuring real-time, label-free monitoring, powerful software, and scalable throughput,...
Multilectrode array ,high throughput screening,cytotoxicity,cell viability,cell mitigration,bioelectronic assay,gmp compliant,glp compliant,cell therapy,cell proliferation,functional assay,cell viability assay,mea assay,viral titer,drug development,drug discovery,assay screening,in vitro ,potency assay,live cell analysis,cell based assay,cell characterization,stem cells,preclincal research,immuno oncology,live cell analysis,and drug screening
Axion biosystems operates in the Biotechnology research industry.
Axion biosystems's revenue is 11m - 100m
Axion biosystems has 51 - 200 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.